🇺🇸 FDA
Patent

US 10653797

Compounds and compositions for targeting brain injuries and methods of use thereof

granted A61KA61K47/62A61K47/6425

Quick answer

US patent 10653797 (Compounds and compositions for targeting brain injuries and methods of use thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/62, A61K47/6425, A61K47/6923, A61K47/6929